Wang Zihang – Trademark Portfolio

Entity Type: 01

Wang Zihang holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 14 (Jewelry) — 2 filings in this category. The portfolio also extends into Class 28 (Toys & Sporting Goods) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include ELOOF, CLIORY, and YUYDXM. The owner is based in Z J.

Yiting Town, Yiwu City

Group 2, Yawen Address Building Village

Z J 321000 , CN

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

YUYDXM
YUYDXM
Registered 2024
CLIORY
CLIORY
Registered 2022
ELOOF
ELOOF
Registered 2020

Trademark Classifications

Wang Zihang's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

14
Jewelry (2 filings)

Precious metals and their alloys; jewellery, precious stones; horological instruments

28
Toys & Sporting Goods (1 filing)

Games and playthings; gymnastic and sporting articles; decorations for Christmas trees

Frequently Asked Questions

How many trademarks does Wang Zihang have?

Wang Zihang has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.

What trademark classes does Wang Zihang file in?

Wang Zihang files trademarks across 2 Nice Classification classes. The most active classes are Class 14 (Jewelry), Class 28 (Toys & Sporting Goods). Class 14 covers precious metals and their alloys; jewellery, precious stones; horological instruments.

What are Wang Zihang's most well-known trademarks?

Wang Zihang's registered trademark portfolio includes well-known marks such as ELOOF, CLIORY, and YUYDXM. These are among 3 currently registered trademarks in the portfolio.

What is Wang Zihang's trademark registration success rate?

Wang Zihang has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.